daniela pinto
Human Advanced Microbiome Project-HMAP
Milan, Italy
Associate Editor
Dermatologic Drugs
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Associate Editors
brian poligone
Rochester General Hospital Research Institute (RGHRI)
Rochester, United States
Associate Editor
Dermatologic Drugs
brian poligone
Rochester Skin Lymphoma Medical Group, PLLC
Fairport, United States
Associate Editor
Dermatologic Drugs
vasanthanathan poongavanam
Uppsala University
Uppsala, Sweden
Associate Editor
Technologies and Strategies to Enable Drug Discovery
francesca prignano
Sezione Dermatologia, Dipartimento di Scienze della Salute, Università di Firenze
Florence, Italy
Associate Editor
Dermatologic Drugs
leon ptaszek
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Associate Editor
Cardiovascular and Hematologic Drugs
lakshmi pulakat
Tufts Medical Center
Boston, United States
Associate Editor
Cardiovascular and Hematologic Drugs
carlos pérez-plasencia
National Autonomous University of Mexico
México City, Mexico
Associate Editor
Anti-Cancer Drugs
peng qu
Zhejiang University of Technology
Hangzhou, China
Associate Editor
Anti-inflammatory and Immunomodulating Agents
dr harish rajak
Guru Ghasidas Vishwavidyalaya
Bilaspur, India
Associate Editor
Anti-Infective Agents
gautam ramani
University of Maryland
Baltimore, United States
Associate Editor
Cardiovascular and Hematologic Drugs
mark j. ranek
Johns Hopkins University
Baltimore, United States
Associate Editor
Cardiovascular and Hematologic Drugs
kaisar raza
Central University of Rajasthan
Ajmer, India
Associate Editor
Dermatologic Drugs
daniel reker
Department of Biomedical Engineering, Pratt School of Engineering, Duke University
Durham, United States
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery
nigel richards
Cardiff University
Cardiff, United Kingdom
Associate Editor
Neurological Drugs
des richardson
School of Environment and Science, Griffith Sciences, Griffith University
Nathan, Australia
Associate Editor
Anti-Cancer Drugs